As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
|
|
|
|
|
|
|
|
|
Market Outlook
In 2019, the global anatomic pathology market was estimated to be USD 16.1 billion and is expected to grow at a CAGR of 5.9% over the forecast period of 2020-2025. Advanced clinical use of biomarkers helps pathologists to assess the pathogenesis of disease at a molecular level and to make clinical decisions to improve the results of the patients.
Get a Free Sample Report with Table of Content - Download Now
Properties and Applications
Anatomic pathology is a medical specialty dealing with the diagnosis of a disease based on organ and tissue, microscopic, biochemical, microscopic, immunological, and molecular analysis. The anatomic pathology market can be divided on the basis of segments like product and service, application, and end-use.
The industry can be broadly categorised based on product and service into:
The anatomic pathology market can be divided on the basis of application as:
The anatomic pathology market can be categorised based on end-use as:
The EMR report looks into the global anatomic pathology markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific regions.
Market Analysis
The growing dependence on pathology tests and procedures based on biomarkers to investigate common malignancy and tumorigenesis is driving the anatomic pathology market. The extensive use of advanced pathology equipment such as staining systems, gross scanning, and electronic microscopes is likely to improve anatomical pathology practices significantly. Digital imaging technologies give accuracy and precision-related advantages over traditional methods, which in turn improves the overall market level of product uptake.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global anatomic pathology market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.
Key Questions Answered in the Report:
1 Preface
1.1 Objectives of the Study
1.1.1 Research Objective
1.1.2 Key Findings of the Report
2 Research Methodology
2.1 Data Extraction
2.2 Data Corroboration
2.3 Market Structure
2.4 Assumptions
2.5 Market Models
3 Introduction
3.1 Market Outlook
3.2 Market Scope and Segmentation
3.3 Additional Insights
4 Executive Summary
4.1 Key Market Developments
4.2 Market Analysis
4.3 Key Players
4.4 Cost Structure
4.5 Market Revenue and Growth
5 Market Dynamics
5.1 Market Driver Analysis
5.2 Market Restraint Analysis
5.3 Industry Challenges
5.4 Industry Opportunities
6 Global Anatomic Pathology Market Analysis
6.1 Global Anatomic Pathology Historical Market (2015-2019) & Forecast (2020-2025)
6.2 Global Anatomic Pathology Market Breakup by Product & Service
6.2.1 Instruments
6.2.1.1 Microtomes & Cryostat
6.2.1.2 Tissue Processor
6.2.1.3 Automatic Stainers
6.2.1.4 Other Products
6.2.2 Consumables
6.2.2.1 Reagents & Antibodies
6.2.2.2 Probes & Kits
6.2.2.3 Others
6.2.3 Services
6.3 Global Anatomic Pathology Market Breakup by Product & Service: Historical Market (2015-2019) & Forecast (2020-2025)
6.3.1 Instruments
6.3.1.1 Microtomes & Cryostat
6.3.1.2 Tissue Processor
6.3.1.3 Automatic Stainers
6.3.1.4 Other Products
6.3.2 Consumables
6.3.2.1 Reagents & Antibodies
6.3.2.2 Probes & Kits
6.3.2.3 Others
6.3.3 Services
6.4 Global Anatomic Pathology Market by Application
6.4.1 Disease Diagnosis
6.4.2 Drug Discovery and Development
6.4.3 Others
6.5 Global Anatomic Pathology Market by Application: Historical Market (2015-2019) & Forecast (2020-2025)
6.5.1 Disease Diagnosis
6.5.2 Drug Discovery and Development
6.5.3 Others
6.6 Global Anatomic Pathology Market by End Use
6.6.1 Research Laboratories
6.6.2 Hospitals
6.6.3 Diagnostic Laboratories
6.6.4 Others
6.7 Global Anatomic Pathology Market by End Use: Historical Market (2015-2019) & Forecast (2020-2025)
6.7.1 Research Laboratories
6.7.2 Hospitals
6.7.3 Diagnostic Laboratories
6.7.4 Others
6.8 Global Anatomic Pathology Market Breakup by Region
6.8.1 North America
6.8.1.1 United States of America
6.8.1.2 Canada
6.8.2 Europe
6.8.2.1 Germany
6.8.2.2 United Kingdom
6.8.2.3 France
6.8.2.4 Italy
6.8.2.5 Others
6.8.3 Asia Pacific
6.8.3.1 China
6.8.3.2 Japan
6.8.3.3 India
6.8.3.4 ASEAN
6.8.3.5 Others
6.8.4 Latin America
6.8.4.1 Brazil
6.8.4.2 Argentina
6.8.4.3 Mexico
6.8.4.4 Others
6.8.5 Middle East & Africa
6.8.5.1 Saudi Arabia
6.8.5.2 United Arab Emirates
6.8.5.3 Nigeria
6.8.5.4 South Africa
6.8.5.5 Others
6.9 Global Anatomic Pathology Breakup by Region: Historical Market (2015-2019) & Forecast (2020-2025)
6.9.1 North America
6.9.1.1 United States of America
6.9.1.2 Canada
6.9.2 Europe
6.9.2.1 Germany
6.9.2.2 United Kingdom
6.9.2.3 France
6.9.2.4 Italy
6.9.2.5 Others
6.9.3 Asia Pacific
6.9.3.1 China
6.9.3.2 Japan
6.9.3.3 India
6.9.3.4 ASEAN
6.9.3.5 Others
6.9.4 Latin America
6.9.4.1 Brazil
6.9.4.2 Argentina
6.9.4.3 Mexico
6.9.4.4 Others
6.9.5 Middle East & Africa
6.9.5.1 Saudi Arabia
6.9.5.2 United Arab Emirates
6.9.5.3 Nigeria
6.9.5.4 South Africa
6.9.5.5 Others
7 SWOT Analysis
7.1 Overview
7.2 Strengths
7.3 Weaknesses
7.4 Opportunities
7.5 Threats
8 Porter’s Five Forces Analysis
8.1 Overview
8.2 Buyer’s Power
8.3 Supplier’s Power
8.4 New Entrants
8.5 Degree of Rivalry
8.6 Substitutes
9 Competitive Landscape & Supplier Analysis
9.1 Thermo Fisher Scientific Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.2 Quest Diagnostics Incorporated (NYSE: DGX)
9.2.1 Company Overview
9.2.2 Financial Analysis
9.3 Laboratory Corporation of America Holdings (NYSE: LH)
9.3.1 Company Overview
9.3.2 Financial Analysis
9.4 Ventana Medical Systems, Inc
9.4.1 Company Overview
9.4.2 Financial Analysis
9.5 Cardinal Health (NYSE: CAH)
9.5.1 Company Overview
9.5.2 Financial Analysis
9.6 Agilent Technologies, Inc. (NYSE: A)
9.6.1 Company Overview
9.6.2 Financial Analysis
9.7 Sakura Finetek USA, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.8 NeoGenomics Laboratories, Inc. ( NASDAQ: NEO)
9.8.1 Company Overview
9.8.2 Financial Analysis
9.9 Others
10 Events and Developments
Additional Customization Available:
11 Trade Data Analysis
11.1 Major Exporting Countries: By Value and Volume
11.2 Major Importing Countries: By Value and Volume
EMR is one of the foremost business intelligence and market research companies with a database of syndicated and customised reports spanning more than 100 industries across global and regional markets. We leverage the knowledge of our highly skilled team of over 100 analysts and more than 3000 independent consultants to provide our clients with thoroughly researched and reliable data tailored to their requirements. We help our clients, who range from Fortune 1000 companies to medium and niche enterprises, make informed strategic decisions through our varied tools and methodology.
Our meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. We understand the distinct nature and requirements for each industry and thus, modify our methodology to best fit the industry in question. Our research methodology uses a combination of cutting-edge analytical tools and the expertise of our highly accomplished team, thus, providing our customers with industry insights that are accurate, actionable, and help them remain ahead of their competition. EMR’ s fine-tuned research methodology and data analysis, formulated through years of cross-industry experience of our team, ensure that our clients are provided with:
Our approach gives our clients a comprehensive assessment of the prevailing and projected industry conditions through the collection, collation, and analysis of data from trusted sources.
Price Assessment
We assess the historical, prevailing, and expected prices of commodities and raw materials by analysing our assiduously collected data from verified primary and secondary sources. Our assessments reflect the market values of related commodities within a region to help our consumers understand the interdependencies and formulate profitable industry strategies. Our price assessments cover both the average global prices along with the prevailing regional prices.
Market Assessment
Our market assessments determine the global and regional production and consumption of the product, according to their value and volume. We identify the key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive overview of the competitive landscape to help our clients make informed strategic decisions. We also take into account the demographic, economic, cultural, and political factors that might influence the market.
We gather market intelligence through our extensive database of reliable secondary sources and our exhaustive interviews with multiple industry stakeholders. The information gathered through our primary and secondary sources help us verify and extrapolate data relating to prices, trade, and market fluctuations along with the latest developments in the industry.
Primary Research
As a part of our primary research, we interact with highly placed industrial professionals possessing an expansive and meticulous insight into the market. We conduct our interviews via mails, telephonic conversations, and one-on-one meetings. Thus, our exhaustive interviews with both buyers and consumers help us provide our clients with verified intelligence regarding the market size, share, drivers, prices, and forecast along with a detailed assessment of your supply chain.
Secondary Research
EMR has access to extensive internal and subscribed databases, which apprise us of the historical and prevailing industry conditions and help us forecast the market for the coming few years. Our secondary research involves a wide array of sources ranging from the annual and financial reports of the key players in the industry to governmental and regulatory databases. We refer to various scientific and industry publications and whitepapers to form a comprehensive understanding of the product and the supply chain. Our wide-ranging research also refers to relevant articles and press releases to provide our customers with an up-to-date understanding of the contemporary market. We derive extensive raw data from our secondary research, which then go through a thorough verification and validation process, to help us formulate an exhaustive understanding of the industry, the supply chain, the competitive landscape, and the product.
Other Analyst Tools and Data Models
Our extensive and intricate data models, formulated through our propriety technological and analytical resources, help you easily comprehend the expansive market data and aid you in framing vital business and industry strategies. Our tools provide you with a cohesive understanding of the industry outlook, taking into account the qualitative and quantitative market variables. Our analytical tools and models are regularly updated according to the changes in the continually evolving market scenarios as well as being adapted to best meet our client’s specific needs. Our research methods involve a blend of the best technological tools used in the industry along with the expertise of our analysts and consultants who can spot and assess the implications of the subtle factors influencing the more complex markets.
Our market assessments take into consideration only those data that are confirmed and are derived from credible and transparent sources. Thus, our clients are presented with accurate and infallible data which can be incorporated into their business strategies.
Before our data is presented to the clients, they undergo an intensive cross-verification and validation process. We corroborate the data gathered through our primary and secondary research by the review and validation of the initial sources along with the verification of the data from other thoroughly vetted sources.
Our qualitative and quantitative assessments are time-sensitive, reflecting the most recent value and volume of the market across regions. By constantly updating our databases and reports to reflect the changes taking place in the industry, our market and price assessments accurately reflect the prevailing industry conditions.
Thus, our rigorous data collection, thorough statistical analysis, and specialist assessments ensure that our clientele has a greater understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors, helping them emerge as the undisputed industry leaders in their respective fields.
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
The global veterinary infectious disease diagnostics market stood at a value of nearly USD 1.5 billion in 2019. The industry is further expected to grow at a CAGR of almost 8.8% in the forecast period...
Vitamin D deficiency has now become a common problem affecting many people worldwide, especially older adults. As vitamin D plays a key role in bone development as well as calcification, many people a...
The global shoulder replacement market is projected to attain a value of USD 3 billion by the end of 2025, growing in the forecast period of 2020-2025 at a CAGR of 7.5%. The shoulder replacement marke...
The global influenza diagnostics market attained a value of USD 657 million in 2019. The influenza diagnostics market is further expected to grow in the forecast period of 2020-2025 at a CAGR of 9% to...
The market is significantly being supported by the integration of digital health technology in bacterial disease rapid diagnostics. North America is among the most significant regions for the market. ...
Buy Full Version
"Anatomic Pathology Market"
Purchase Enquiry